ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief

January 4, 1980

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Stovall To Step Down As NCCS President At End Of 2008.

September 21, 2007

National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms

May 26, 1995

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990